Literature DB >> 21111718

Linking hypoxic and oxidative insults to cell death mechanisms in models of ALS.

Renshi Xu1, Chengsi Wu, Xiong Zhang, Qiong Zhang, Yunzhu Yang, Juan Yi, Rongwei Yang, Yuhui Tao.   

Abstract

Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease that is characterized by a progressive, selective loss of motor neurons (MN) in brain and spinal cord. The mechanisms of selective and age-dependent MN degeneration in ALS have not been defined. Recent studies suggest that the elevation of intracellular oxidative toxicity contributes to death of MN, but the molecular pathways remain largely unknown. In order to study the possible molecular pathways that the oxidative toxicity induced MN death in ALS, a MN-like cell NSC34, a primary neuronal cell (PNC) of mouse prontal cortex, and a G93A-SOD1 transgenic mouse model were used. Exposure of NSC34 and PNC to cobalt chloride or chronic sustained hypoxic conditions showed a dramatic increase of cellular Hif-1α (hypoxia inducing factor-1α), HO-1 (heme oxygenases-1), and UCP4 (uncoupling protein 4) expression by Western blot analysis, accompanied with increasing cellular apoptosis by histone protein release assay. In an ALS mouse model, the caspase 3 activation, Aif (apoptosis inducing factor), cytochrome c redistribution in MN of spinal cord significantly increased at 70days of disease progression, and Hif-1α expression significantly increased at whole disease stages by an immunohistochemical positive cell counting and Western blot analysis, respectively. The data on this in vitro and in vivo study suggested that oxidative toxicity promoted multiple molecular pathways associated with MN death in ALS and at least were partially associated with the changes of Hif-1α, HO-1, UCP4 expressive increment, caspase 3 activation and Aif, cytochrome c redistribution. Copyright Â
© 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21111718     DOI: 10.1016/j.brainres.2010.11.056

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  13 in total

1.  Early and progressive impairment of spinal blood flow-glucose metabolism coupling in motor neuron degeneration of ALS model mice.

Authors:  Kazunori Miyazaki; Kazuto Masamoto; Nobutoshi Morimoto; Tomoko Kurata; Takahumi Mimoto; Takayuki Obata; Iwao Kanno; Koji Abe
Journal:  J Cereb Blood Flow Metab       Date:  2011-11-09       Impact factor: 6.200

Review 2.  Mechanisms of altered redox regulation in neurodegenerative diseases--focus on S--glutathionylation.

Authors:  Elizabeth A Sabens Liedhegner; Xing-Huang Gao; John J Mieyal
Journal:  Antioxid Redox Signal       Date:  2012-01-06       Impact factor: 8.401

Review 3.  Advances in cellular models to explore the pathophysiology of amyotrophic lateral sclerosis.

Authors:  C Veyrat-Durebex; P Corcia; A Dangoumau; F Laumonnier; E Piver; P H Gordon; C R Andres; P Vourc'h; H Blasco
Journal:  Mol Neurobiol       Date:  2013-11-07       Impact factor: 5.590

4.  Uncoupling protein-4 (UCP4) increases ATP supply by interacting with mitochondrial Complex II in neuroblastoma cells.

Authors:  Philip Wing-Lok Ho; Jessica Wing-Man Ho; Ho-Man Tse; Danny Hon-Fai So; David Chi-Wai Yiu; Hui-Fang Liu; Koon-Ho Chan; Michelle Hiu-Wai Kung; David Boyer Ramsden; Shu-Leong Ho
Journal:  PLoS One       Date:  2012-02-29       Impact factor: 3.240

Review 5.  Implications of white matter damage in amyotrophic lateral sclerosis (Review).

Authors:  Ting Zhou; Tina Khorshid Ahmad; Kiana Gozda; Jessica Truong; Jiming Kong; Michael Namaka
Journal:  Mol Med Rep       Date:  2017-08-07       Impact factor: 2.952

6.  Single injection of sustained-release prostacyclin analog ONO-1301-MS ameliorates hypoxic toxicity in the murine model of amyotrophic lateral sclerosis.

Authors:  Satoru Tada; Tatsusada Okuno; Mikito Shimizu; Yoshiki Sakai; Hisae Sumi-Akamaru; Makoto Kinoshita; Kazuya Yamashita; Eri Sanda; Chi-Jing Choong; Akiko Namba; Tsutomu Sasaki; Toru Koda; Kazushiro Takata; Shigeru Miyagawa; Yoshiki Sawa; Yuji Nakatsuji; Hideki Mochizuki
Journal:  Sci Rep       Date:  2019-03-27       Impact factor: 4.379

7.  Mitochondrial neuronal uncoupling proteins: a target for potential disease-modification in Parkinson's disease.

Authors:  Philip Wl Ho; Jessica Wm Ho; Hui-Fang Liu; Danny Hf So; Zero Hm Tse; Koon-Ho Chan; David B Ramsden; Shu-Leong Ho
Journal:  Transl Neurodegener       Date:  2012-01-13       Impact factor: 8.014

8.  Intermittent hypoxia can aggravate motor neuronal loss and cognitive dysfunction in ALS mice.

Authors:  Sung-Min Kim; Heejaung Kim; Jeong-Seon Lee; Kyung Seok Park; Gye Sun Jeon; Jeeheun Shon; Suk-Won Ahn; Seung Hyun Kim; Kyung Min Lee; Jung-Joon Sung; Kwang-Woo Lee
Journal:  PLoS One       Date:  2013-11-26       Impact factor: 3.240

9.  Early gene expression changes in spinal cord from SOD1(G93A) Amyotrophic Lateral Sclerosis animal model.

Authors:  Gabriela P de Oliveira; Chrystian J Alves; Gerson Chadi
Journal:  Front Cell Neurosci       Date:  2013-11-18       Impact factor: 5.505

10.  Long-term interleukin-33 treatment delays disease onset and alleviates astrocytic activation in a transgenic mouse model of amyotrophic lateral sclerosis.

Authors:  Paula Korhonen; Eveliina Pollari; Katja M Kanninen; Ekaterina Savchenko; Šárka Lehtonen; Sara Wojciechowski; Yuriy Pomeshchik; Ludo Van Den Bosch; Gundars Goldsteins; Jari Koistinaho; Tarja Malm
Journal:  IBRO Rep       Date:  2019-01-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.